Top Section/Ad
Top Section/Ad
Most recent
Calendar quirk could keep issuance going in December
◆ Praemia refis at a tighter coupon ◆ Schneider lands tight at the short end ◆ Minimal concessions needed
French biotech seeks to accelerate cancer vaccine program
More articles/Ad
More articles/Ad
More articles
-
China’s YishengBio is planning to list in Hong Kong, having filed an IPO application with the bourse on Monday. -
SK Bioscience has priced its IPO at the top of the marketed range, raising W1.49tr ($1.32bn) from South Korea’s largest listing in four years.
-
Colombia has increased its external funding programme for the year to over $10bn after forecasting a larger 2021 fiscal deficit than it recorded in 2020, exacerbating concerns about the government’s ability to maintain its investment grade credit rating.
-
Pablo de Ramón-Laca is director general of the treasury and financial policy at Spain's Ministry of Economic Affairs and Digital Transformation. That places him in charge of the world's ninth largest sovereign debt stock, according to S&P data, for a country pummelled by the Covid-19 pandemic. Spain has the second highest number of cases in the EU and the seventh highest in the world. But even that is not the full story of the pandemic's impact.
-
UK small and medium sized enterprises are at risk of collapsing under their coronavirus pandemic debt burdens, warned a member of an influential cross-party parliamentary committee in the wake of Wednesday's budget announcement.
-
Sixt, the German car rental company, has refinanced a coronavirus pandemic crisis era loan, swapping out domestic state support for a fully commercial bank line as vaccinations provide growth hopes.
